Bausch Health Companies (BHC) Interest & Investment Income (2009 - 2026)

Bausch Health Companies (BHC) reported Interest & Investment Income of $10.0 million for Q1 2026, down 9.09% on a YoY basis from $11.0 million in Q1 2025, and up 11.11% sequentially from $9.0 million in Q4 2025.

Bausch Health Companies (BHC) Interest & Investment Income (2009 - 2026) Analysis & Trends

Bausch Health Companies (BHC) has 18 years of Interest & Investment Income data on file, last reported at $10.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Interest & Investment Income fell 9.09% year-over-year to $10.0 million; the trailing twelve-month figure through Mar 2026 stood at $47.0 million (up 34.29% YoY), and the FY2025 full-year result was $48.0 million, up 45.45% from the prior year.
  • Interest & Investment Income advanced to $10.0 million in Q1 2026, from $9.0 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $15.0 million in Q3 2025 to a low of $2.0 million in Q1 2022.
  • A 5-year average of $7.7 million and a median of $7.0 million in 2023 frame the typical range for Interest & Investment Income.
  • Across the five-year window, Interest & Investment Income soared 500.0% in 2022 and decreased 9.09% in 2026, its largest moves.
  • Tracing BHC's Interest & Investment Income over 5 years: stood at $6.0 million in 2022, then climbed by 16.67% to $7.0 million in 2023, then grew by 28.57% to $9.0 million in 2024, then changed by 0.0% to $9.0 million in 2025, then climbed by 11.11% to $10.0 million in 2026.
  • Business Quant data shows BHC's Interest & Investment Income at $10.0 million in Q1 2026, $9.0 million in Q4 2025, and $15.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 32.85 Mn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 41.80 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 28.10 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Bausch Health Companies 1.68 Bn 367.46 Mn 2.52 Bn 10.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.00 Mn
Dec 31, 2025 9.00 Mn
Sep 30, 2025 15.00 Mn
Jun 30, 2025 13.00 Mn
Mar 31, 2025 11.00 Mn
Dec 31, 2024 9.00 Mn
Sep 30, 2024 7.00 Mn
Jun 30, 2024 8.00 Mn
Mar 31, 2024 9.00 Mn
Dec 31, 2023 7.00 Mn
Sep 30, 2023 6.00 Mn
Jun 30, 2023 7.00 Mn
Mar 31, 2023 6.00 Mn
Dec 31, 2022 6.00 Mn
Sep 30, 2022 3.00 Mn
Jun 30, 2022 3.00 Mn
Mar 31, 2022 2.00 Mn
Dec 31, 2021 1.00 Mn
Sep 30, 2021 2.00 Mn
Jun 30, 2021 2.00 Mn